Cary Street Partners Investment Advisory’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-300
Closed -$4.4K 1757
2023
Q1
$4.4K Sell
300
-200
-40% -$3.04K ﹤0.01% 1359
2022
Q4
$7.75K Buy
+500
New +$7.59K ﹤0.01% 1212

Other funds holding DIAX

Cary Street Partners Investment Advisory's DIAX Position: Q2 2023 in Review

Cary Street Partners Investment Advisory sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q2 2023, closing a stake of 300 shares — an estimated $4.4K sold.

Cary Street Partners Investment Advisory first reported a position in DIAX in Q4 2022 and held it in 2 quarters. The position peaked at $7.75K in Q4 2022. 82 funds tracked by Wall St. Rank hold DIAX as of Q2 2023.

  • Cary Street Partners Investment Advisory reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q2 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 300 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q2 2023, an estimated $4.4K.
  • Cary Street Partners Investment Advisory first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2022 and held it in 2 quarters.
  • Cary Street Partners Investment Advisory's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $7.75K in Q4 2022.
  • 82 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q2 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2023, filed 10 Aug 2023.